omega-n-methylarginine has been researched along with pentoxifylline in 6 studies
Studies (omega-n-methylarginine) | Trials (omega-n-methylarginine) | Recent Studies (post-2010) (omega-n-methylarginine) | Studies (pentoxifylline) | Trials (pentoxifylline) | Recent Studies (post-2010) (pentoxifylline) |
---|---|---|---|---|---|
4,411 | 344 | 336 | 4,437 | 657 | 943 |
Protein | Taxonomy | omega-n-methylarginine (IC50) | pentoxifylline (IC50) |
---|---|---|---|
Acetylcholinesterase | Homo sapiens (human) | 6.6 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 5 (83.33) | 18.2507 |
2000's | 1 (16.67) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bienzle, U; Chaves, MF; Kremsner, PG; Neifer, S; Rudolph, R | 1 |
Berkenboom, G; Fang, ZY; Fontaine, J; Goldman, M; Unger, P | 1 |
Grabowska, A; Lauterbach, R; Marcinkiewicz, J | 1 |
Cai, B; Greenberg, S; Hyman, A; Kolls, J; Lippton, H; Nelson, S; Summer, WR; Wang, Y; Xie, J | 1 |
Belladonna, ML; Campanile, F; Fioretti, MC; Giampietri, A; Grohmann, U; Puccetti, P | 1 |
Bilsborough, W; Dembo, L; Green, D; O'Driscoll, G; Stanton, K; Taylor, R; Weerasooriya, R | 1 |
1 trial(s) available for omega-n-methylarginine and pentoxifylline
Article | Year |
---|---|
Effect of lowering tumour necrosis factor-alpha on vascular endothelial function in Type II diabetes.
Topics: Acetylcholine; Analysis of Variance; Brachial Artery; Cross-Over Studies; Diabetes Mellitus, Type 2; Double-Blind Method; Endothelium, Vascular; Female; Humans; Male; Middle Aged; Nitric Oxide Synthase; Nitroglycerin; Nitroprusside; omega-N-Methylarginine; Pentoxifylline; Plethysmography; Regional Blood Flow; Tumor Necrosis Factor-alpha; Ultrasonography; Vasodilator Agents | 2002 |
5 other study(ies) available for omega-n-methylarginine and pentoxifylline
Article | Year |
---|---|
Interferon-gamma induced lethality in the late phase of Plasmodium vinckei malaria despite effective parasite clearance by chloroquine.
Topics: Animals; Arginine; Chloroquine; Deferoxamine; Female; Immunization; Interferon-gamma; Liver; Malaria; Mice; Mice, Inbred BALB C; omega-N-Methylarginine; Pentoxifylline; Tumor Necrosis Factor-alpha | 1992 |
Prevention of cyclosporine A-induced vascular toxicity by pentoxifylline.
Topics: Acetylcholine; Animals; Arginine; Colforsin; Cyclosporine; Endothelium, Vascular; Male; Muscle Contraction; Muscle Relaxation; Muscle, Smooth, Vascular; Neuromuscular Depolarizing Agents; Nitric Oxide; Nitroprusside; omega-N-Methylarginine; Pentoxifylline; Phenylephrine; Rats; Rats, Inbred Strains; Vascular Diseases | 1991 |
Effect of pentoxifylline on nitric oxide released by murine macrophages.
Topics: Amino Acid Oxidoreductases; Animals; Arginine; Cells, Cultured; Endotoxins; Interferon-gamma; Lipopolysaccharides; Macrophages, Peritoneal; Mice; Mice, Inbred CBA; Nitric Oxide; Nitric Oxide Synthase; omega-N-Methylarginine; Pentoxifylline; Staphylococcus epidermidis; Tumor Necrosis Factor-alpha | 1995 |
Tumor necrosis factor-alpha inhibits endothelium-dependent relaxation.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Acetylcholine; Animals; Arginine; Cattle; Endothelium, Vascular; Histamine; Ibuprofen; In Vitro Techniques; Muscle Contraction; Muscle Relaxation; Muscle, Smooth, Vascular; Norepinephrine; omega-N-Methylarginine; Pentoxifylline; Potassium Chloride; Prostaglandin Endoperoxides, Synthetic; Pulmonary Artery; Pulmonary Veins; Tumor Necrosis Factor-alpha; Vasoconstrictor Agents | 1993 |
Evidence for tumor necrosis factor alpha as a mediator of the toxicity of a cyclooxygenase inhibitor in Gram-negative sepsis.
Topics: Animals; Cyclooxygenase Inhibitors; Female; Gene Amplification; Gene Expression; Indomethacin; Male; Mice; Mice, Inbred BALB C; Mice, Inbred DBA; Nitric Oxide; omega-N-Methylarginine; Pentoxifylline; Polymerase Chain Reaction; Pseudomonas aeruginosa; Pseudomonas Infections; RNA, Messenger; Shock, Septic; Tumor Necrosis Factor-alpha | 1996 |